BHC

#1660
Bausch Health Companies Inc. Common Stock
5.3 7 USD
-1.10%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
5.31
5.37
Range Annuel
4.41
8.68
Changement quotidien
-1.10%
Changement Mensuel
-8.98%
Evolution sur 6 mois
-18.14%
Changement Annuel
+18.28%
Clôture Précédente
5.4 3
Open
5.3 3
Low
5.3 1
High
5.3 7
Volume
796
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes
Trimestriel Annuel
  • Market Capitalization 2.01 B
  • Employee 20 K
  • Founded N/A
  • CEO Thomas Appio
  • Website www.bauschhealth.com
  • Headquarter New Jersey, United States
  • FIGI BBG000DLFM21
  • Industry Fabricants de Médicaments — Spécialités et Génériques
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
16.55
ratio cours/chiffre d'affaires
0.25

Bausch Health Companies Inc. Common Stock

Bausch Health Companies Inc. is a global, diversified Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neuroscience, dermatology, dentistry, medical aesthetics, and international pharmaceuticals. Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America.

Nouvelles